RecruitingNCT06532890
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
Sponsor
Inova Health Care Services
Enrollment
150 participants
Start Date
Feb 6, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to discover circulating microRNAs (associated with drug doses and levels) that can be used to characterize the overall immune state in pediatric heart transplant patients and predict patients that will go on to develop infection and rejection. MicroRNAs (miRs) are small, non-coding RNA molecules that regulate gene expression and serve as molecular biomarkers found in the circulation.
Eligibility
Max Age: 18 Years
Inclusion Criteria4
- Age ≤ 18 years at time of transplant listing
- Subject is within 10-50 days post-orthotopic heart transplant at time of enrollment.
- Planned follow-up at the transplant center for a minimum of one-year.
- Caregiver able and willing to comply with the study visit schedule, study procedures, and study requirements.
Exclusion Criteria6
- Recipient of a multi-organ transplant
- History of prior solid organ transplant before the index heart transplant
- Ongoing mechanical circulatory support or hemodynamic instability after transplant
- Active infection requiring either a) hospitalization or b) treatment with antimicrobial drugs (does not include prophylaxis for infection or suppressive antibiotics given after transplant)
- History of treated rejection prior to study enrollment
- Inability to collect specified blood volume after enrollment and prior to 50 days post-transplant
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06532890
Related Trials
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
NCT001069251 location
Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure
NCT066289732 locations
Cardiac Remodelling Following Endovascular Repair of the Aorta
NCT074154472 locations
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
NCT069397515 locations
Recovery From ICUAW Following Severe Respiratory and Cardiac Failure
NCT037534121 location